COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease
Jaguar Health's crofelemer shows promise in reducing TPN needs for MVID and SBS-IF patients. Investor webcast to review proof-of-concept study results presented at ELITE PED-GI Congress -
COMMUNIQUÉ DE PRESSE
FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
FamiCord AG reports 6.6% revenue growth to EUR 82.2 million in 2024, with EBITDA reaching EUR 8.8 million. Business development stabilizes in Germany. Company continues international expansion -
-
-
COMMUNIQUÉ DE PRESSE
VAZIVA SA: Invitation webinaire actionnaires individuels le mercredi 14 mai 2025 à 18h00 - Présentation des Résultats annuels 2024
Invitation webinaire pour actionnaires individuels le mercredi 14 mai 2025 à 18h00, présentation des Résultats annuels 2024 par Vaziva SA. Inscrivez-vous via le lien fourni -
-
-
-
